The Global Cardiovascular-Liver-Metabolic Syndemic: A Growing Epidemic

Strategic Insights -

A comprehensive review published in the journal Nature Reviews Cardiology reveals the alarming growth of a global syndemic, characterized by the coexistence of metabolic-dysfunction-associated steatotic liver disease, type 2 diabetes mellitus, obesity, and cardiovascular disease. The research highlights the urgent need for a unified framework to address the complex interplay between these diseases, which are inextricably linked and sharing socioeconomic influences.

Key Takeaways:

  • The global cardiovascular-liver-metabolic (CLM) syndemic is characterized by the coexistence and interaction of metabolic-dysfunction-associated steatotic liver disease, type 2 diabetes mellitus, obesity, and cardiovascular disease.
  • The CLM syndemic is driven by shared mechanisms and socioeconomic influences, leading to a synergy of epidemics that coexist and interact.
  • The proposed micro-meso-macro framework aims to integrate strategies to improve risk prediction and precision prevention, while keeping communities at the heart of CLM health promotion.
  • Interventions to eliminate inequities in the social and commercial determinants of health, from communities to healthcare systems, are necessary to address the CLM disease epidemics simultaneously.
  • Multisystem interventions are required to address the trajectories of the CLM disease epidemics simultaneously.

Statistics:

  • The global prevalence of metabolic-dysfunction-associated steatotic liver disease, type 2 diabetes mellitus, obesity, and cardiovascular disease is increasing, with shared mechanisms and socioeconomic influences driving the CLM syndemic.
  • The proposed micro-meso-macro framework aims to improve risk prediction and precision prevention, while keeping communities at the heart of CLM health promotion.
  • Interventions to eliminate inequities in the social and commercial determinants of health are necessary to address the CLM disease epidemics simultaneously.

Sources:

  • Chew, N. W., et al. The global cardiovascular-liver-metabolic syndemic: epidemiology, trends and challenges. Nature Reviews Cardiology, 2025.
  • Nature Publishing Group. Nature Reviews Cardiology. www.nature.com/nrcardio/
  • NewsRx. Researchers at National University Heart Centre Target Cardiovascular Research (The global cardiovascular-liver-metabolic syndemic: epidemiology, trends and challenges). Obesity & Diabetes Week. October 20, 2025; p 132